GBMB Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Inovio Pharmaceuticals Inc

Watchlist Manager

Watchlist

Price: 11.94 EUR 7.76% Market Closed

Market Cap: €22.6m

I	Inovio Pharmaceuticals Inc F:GBMB	US
A	A10 Networks Inc F:8A0	US

Profitability Summary

Inovio Pharmaceuticals Inc's profitability score is 9/100. We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-132 959%

Negative 3Y Average Operating Margin

-41 491%

Declining Operating Margin

-1 774% > -132 959%

Negative Net Margin

-130 086%

Negative 3Y Average Net Margin

-41 000%

Declining Net Margin

-1 751% > -130 086%

Negative Free Cash Flow Margin

-136 164%

Negative 3Y Average Free Cash Flow Margin

-40 348%

Declining Free Cash Flow Margin

-1 802% > -136 164%

Negative ROE

-183%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-668%

ROIC is Increasing

-1 045% > -673%

View All

Hide

Collapse

9 / 100

Profitability
Score

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.